It has been reported that the melanogenic activity can be inhibited by antioxidants, like a-tocopherol and hydrocoumarins, 1) and that reduced glutathione (GSH), an important biological reductant, plays a role in the modulation of the melanogenic process.
The requirement of cAMP for melanogenesis is quite clear for pigmentation. cAMP also increases tyrosinase mRNA and promotes increased microphthalmia transcription factor (MITF) expression. MITF is a melanocyte-specific transcription factor crucial for melanocyte survival, development and differentiation through the activation of protein kinase A (PKA). 5) PKA is a serine/threonine kinase that is an inactive tetramer consisting of two regulatory subunits and two catalytic subunits, and its activation occurs by the binding of cAMP to its regulatory subunits and then releasing its catalytic subunits from the regulatory subunits. 6) Recently, we reported that 4,4Ј-dihydroxybiphenyl (44Ј-BP) has a melanogenesis inhibitory effect through the inhibition of tyrosinase and reduction of melanin content. 7) However, the underlying process by which tyrosinase activity and melanogenesis were inhibited by 44Ј-BP was not elucidated. In this current study, we attempted to investigate the effect of 44Ј-BP on major cellular regulators involved in melanogenesis in B16 melanoma cells (B16 cells). The analysis was carried out by quantifying amounts of tyrosinase and MITF proteins, cAMP levels, phosphorylated PKA, and GSH and oxidized glutathione (GSSG) levels. Cell Culture System B16 cells (from Korean Cell Line Bank) were cultured in DMEM with 10% fetal bovine serum (FBS; Gibco) and penicillin/streptomycin (100 IU/50 mg/ml) in a humidified atmosphere containing 5% CO 2 in air at 37°C. B16 cells were cultured in 24-well plates for each assay.
MATERIALS AND METHODS

Materials
All the experiments were determined in triplicate and repeated three times to ensure reproducibility.
GSH and GSSG Assay Assays for GSH and GSSG were carried out by the method of Pandey and Katiyar. 8) Twenty-five percent of the meta-phosphoric acid-added cell pellets were centrifuged at 12000 rpm for 10 min, and the supernatant was taken for assay. For GSH, 1 mM EDTA-50 mM phosphate buffer was added to the supernatant followed by ophthaladehyde. After 20 min at room temperature, the fluorescence was measured at excitation wavelength of 360 nm and emission wavelength of 460 nm. GSSG was assayed after preincubated with N-ethylmaleimide for 20 min and 0.1 M NaOH was substituted for 1 mM EDTA-50 mM phosphate buffer.
Quantitation of cAMP To measure intracellular cAMP levels, an enzyme immunoassay kit was used. In brief, B16 cells (7ϫ10 4 ) were lyzed in 0.1 M of HCl to inhibit phosphodiesterase activity. Supernatants were collected, neutralized, and diluted. Following neutralization and dilution, a fixed amount of cAMP conjugate (alkaline phosphatase-labeled cAMP) was added to compete with cAMP present in the cell lysate. The cAMP substrate solution was added to the wells to determine binding enzyme activity. The color development was stopped and the absorbance was read at 405 nm. The intensity of the color was inversely proportional to the concentration of cAMP in the cell lysates.
Protein Preparation and Western Blotting The B16 cells (5ϫ10 4 ) were plated on 24-well multi-dishes and incubated in the presence or absence of 100 nm a-MSH. The cells were then incubated for 24 h with or without 44Ј-BP and washed twice in PBS at 4°C. Total cell lysates were lysed in lysis buffer [40 mM Tris (pH 8.0), 120 mM NaCl, 0.5% Nonidet P-40 (NP-40), 0.1 mM sodium orthovanadate, 2 mg/ml aprotinin, 2 mg/ml leupeptin, and 100 mg/ml phenylmethylsulfonyl fluoride (PMSF)]. The supernatant was collected and protein concentrations were then determined with protein assay reagents (Pierce, Rockford, IL, U.S.A.). For the Western blotting, equal amount of proteins were boiled for 2 min and chilled on ice, subjected to 8-10% sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE), and electrophoretically transferred to a PVDF membrane. The proteins were visualized with the enhanced chemiluminescence (ECL) detection system (Amersham Life Science).
Statistical Analysis Data were collected as meanϮstan-dard error (nϭ3) and the biological significance pϽ0.05 was determined by the Student's t-test.
RESULTS
Effect of 44-BP on GSH and GSSG Levels and GSH/GSSG Ratio
In the present study, the inhibitory action of 44Ј-BP on melanogenesis was examined by assessing GSH and GSSG levels and the GSH/GSSG ratio. Table 1 shows that intracellular GSH levels in B16 melanoma cells were enhanced by 44Ј-BP, while GSSG levels were suppressed. Consequently, the GSH/GSSG ratio was increased by 44Ј-BP, indicating an increased intracellular reducing power, which is expected to play a significant role in the regulation of melanogenesis.
Downregulation of Tyrosinase and MITF by 44-BP Western blotting analysis revealed that tyrosinase protein levels were reduced by 44Ј-BP. To further investigate the involvement of transcription factors in the regulation of melanogenesis by 44Ј-BP, MITF protein levels were determined, finding that MITF protein levels were reduced in the B16 cells treated with 44Ј-BP, as shown in Fig. 1 .
Effect of 44-BP on cAMP and PKA Activation Since melanin biosynthesis requires cAMP, intracellular levels of cAMP was measured in the presence or absence of 44Ј-BP to investigate the effect of 44Ј-BP on cAMP levels. Data in Fig.  2 show that 44Ј-BP (25 mM) significantly reduced intracellular cAMP levels in a-MSH-untreated cells. This suppressive effect of 44Ј-BP on cAMP levels was also observed in a-MSH-treated cells, leading to the possibility that 44Ј-BP modulates the cAMP-dependent melanogenesis likely by reducing cAMP.
To investigate whether 44Ј-BP might affect PKA activation, the amount of phosphorylated Ser 96 PKA regulatory type IIa subunit, pPKA (51 kDa) which is evidence of PKA activation was determined. The amount of phosphorylated PKA (pPKA) was measured in the presence or absence of 44Ј-BP. As shown by Fig. 3, 44Ј -BP effectively reduced pPKA, suggesting that a-MSH-induced pigmentation process was suppressed by 44Ј-BP in B16 cells.
DISCUSSION
In our previous work, we showed that 44Ј-BP reduced melanin content via the inhibition of tyrosinase, 7) and in the same report, data on its non-cytotoxic nature were presented. 7) In the current study, we attempted to identify those cellular factors involved in melanogenesis that are affected by the inhibitory action of 44Ј-BP. Our working hy- 
Fig. 1. Effect of 44Ј-BP on Tyrosinase and MITF Proteins
Protein levels were measured by Western blotting. The samples were resolved in 10% SDS-PAGE gels and transferred to PVDF membrane. Specific detection of tyrosinase was performed with the antibodies aPEP7. Arrows indicate the representative band, and significant changes were noted. The data presented are representative of at least 3 separate experiments.
Fig. 2. Effect of 44Ј-BP on cAMP in MSH-Untreated, and -Treated B16 Cells
The B16 cells (5ϫ10 4 ) were plated on 24-well, multi-dishes and incubated in the presence or absence of 100 nm a-MSH. The cells were then incubated for 40 min in various amounts of 44Ј-BP (0-25 mM) and then were assayed for cAMP concentration, as detailed in Materials and Methods. Results are reported as pmol/7ϫ10 pothesis was that 44Ј-BP inhibits the melanin biosynthesis process through a reductive power shown by others. 1, 9) In addition, we examined whether 44Ј-BP reduces cAMP content, thereby suppressing the activation of PKA and melanocyte-specific transcription factor (MITF), which led to the suppression of tyrosinase protein levels, and subsequently resulted in melanogenesis inhibitory activity.
One interesting finding from the present study is the possible dual effect that 44Ј-BP exhibited on antimelanogenic activity; as an antioxidant, it was found to inhibit tyrosinase directly, 7) and at the same time, enhanced GSH levels. Our data on increased GSH are in agreement with others', 1, 9) who reported on the important role of GSH in the inhibition of melanogenesis through its ability to dampen the formation of melanosomes from premelanosomes.
10) It has been suggested that a-tocopherol inhibits oxidative polymerization of phenylalanines during melanin formation and that free radicals and peroxides deplete intracellular GSH.
11)
The current data on decreased tyrosinase protein levels by 44Ј-BP are similar to what we have seen in our previous study with the inhibition of tyrosinase by 44Ј-BP, 7) and a report by other investigators on miconazole.
12) It was reported that the expression of melanogenic enzyme, tyrosinase was enhanced by cAMP-elevating agents, 13) showing the requirement of cAMP for optimal melanogenic activity. Our current work confirms the role of cAMP by observing suppressed cAMP with reduced tyrosinase by 44Ј-BP.
It is known that a-MSH stimulates elevation of the intracellular cAMP content, and the activation of PKA, 6) which are all modulated by 44Ј-BP.
MITF is one of the pivotal transcriptional regulators of tyrosinase, and thus it plays an important role in melanogenesis and in the regulation of MITF expression via a-MSH, showing a direct mechanistic link to pigmentation.
14) The cAMP elevating agents, a-MSH and forskolin, stimulate a rapid increase in MITF mRNA and protein levels in both melanoma cell lines and primary melanocytes. 15) In the current study, the protein levels of both tyrosinase and MITF were shown to decrease, indicating melanogenesis suppression by 44Ј-BP through the MITF transcriptional mechanism, which is known to play an important role in melanogenesis. In this regard, a recent study of epigallocatechin-3-gallate on the inhibition of melanin and MITF 16) is related to our present work. In summary, the suppression of melanogenesis by 44Ј-BP in B16 cells was likely related to its antioxidant capacity, coupled with its ability to enhance intracellular GSH levels. Our current findings on reduced tyrosinase and MITF protein levels and the attenuation of cAMP and PKA are consistent with published data 7) on the antimelanogenic activity. Based on data obtained from our investigations and the studies of others, we propose that the suppression of tyrosinase, MITF, cAMP, and PKA activation may be the major factors underlying 44Ј-BP's antimelanogenic activity. Vol. 29, No. 1 Fig. 3 . Attenuation of the Activation of PKA of 44Ј-BP in a-MSH-Stimulated B16 Cells
Western blotting was performed using phospho-specific antibody pSer 96 (pPKA), and bands were visualized using ECL procedure (Amersham). Statistical significance difference between the a-MSH group and a-MSH plus 44Ј-BP groups, * pϽ0.05, * * pϽ0.01.
